Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors

被引：0
|
作者：
Sander, Michael [1 ]
Stukalin, Igor [2 ]
Vallerand, Isabelle A. [3 ]
Goutam, Siddhartha [4 ]
Ewanchuk, Benjamin W. [1 ]
Meyers, Daniel E. [2 ]
Pabani, Aliyah [2 ]
Morris, Don [2 ]
Heng, Daniel Y. C. [2 ]
Cheng, Tina [2 ]
机构：
[1] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada
[2] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[3] Univ Calgary, Dept Dermatol, Calgary, AB, Canada
[4] Univ Alberta, Fac Med, Edmonton, AB, Canada
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
27995
引用
收藏
页码：AB170 / AB170
页数：1
相关论文
共 50 条
  • [1] Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors
    Sander, Michael S.
    Stukalin, Igor
    Vallerand, Isabelle A.
    Goutam, Siddhartha
    Ewanchuk, Benjamin W.
    Meyers, Daniel E.
    Pabani, Aliyah
    Morris, Don G.
    Heng, Daniel Y. C.
    Cheng, Tina
    CANCER MEDICINE, 2021, 10 (08): : 2618 - 2626
  • [2] Outcomes of immune checkpoint inhibitors in patients with metastatic uveal melanoma treated with tebentafusp
    Koch, E. C.
    Ceballos, D. P. Arteaga
    Vilbert, M.
    Lajkosz, K.
    Muniz, T. Pimentel
    Hirsch, I.
    Ribeiro, M. F. Silva Almeida
    Mantle, L.
    Anczurowski, M.
    Hogg, D.
    Saibil, S.
    Spreafico, A.
    Krema, H.
    Butler, M. O.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S928 - S928
  • [3] Immune Prognostic Index as a predictor of survival in patients with metastatic melanoma treated with immune checkpoint inhibitors
    Stukalin, Igor
    Suo, Aleksi
    Vallerand, Isabelle A.
    Lewinson, Ryan
    Heng, Daniel Y. C.
    Bebb, D. Gwyn
    Morris, Don G.
    Cheng, Tina
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB100 - AB100
  • [4] Immune Checkpoint Inhibitors in the Treatment of Metastatic Uveal Melanoma
    Kuo, J. C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 60 - 61
  • [5] Surgery in patients with metastatic melanoma treated with immune checkpoint inhibitors
    Janssen, Josephine C.
    Huibers, Anne E.
    Grunhagen, Dirk J.
    Bagge, Roger Olofsson
    SCANDINAVIAN JOURNAL OF SURGERY, 2025,
  • [6] Immune profiling of metastatic uveal melanoma and response to immune checkpoint inhibitors.
    Shao, Yusra F.
    Baca, Yasmine
    Xiu, Joanne
    Vanderwalde, Ari M.
    In, Gino Kim
    Hoon, Dave S. B.
    Domingo-Musibay, Evidio
    Darabi, Sourat
    Eisenberg, Burton Larry
    Sato, Takami
    Gibney, Geoffrey Thomas
    Mamdani, Hirva
    Moser, Justin C.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Development of a Metastatic Uveal Melanoma Prognostic Score (MUMPS) for Use in Patients Receiving Immune Checkpoint Inhibitors
    Kelly, Deirdre
    Rose, April A. N.
    Muniz, Thiago Pimentel
    Hogg, David
    Butler, Marcus O.
    Saibil, Samuel D.
    King, Ian
    Kamil, Zaid Saeed
    Ghazarian, Danny
    Ross, Kendra
    Iafolla, Marco
    Araujo, Daniel, V
    Waldron, John
    Laperriere, Normand
    Krema, Hatem
    Spreafico, Anna
    CANCERS, 2021, 13 (14)
  • [8] The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors
    Dravillas, Caroline E.
    Coleman, Samuel S.
    Hoyd, Rebecca
    Caryotakis, Griffin
    Denko, Louis
    Chan, Carlos H. F.
    Churchman, Michelle L.
    Denko, Nicholas
    Dodd, Rebecca D.
    Eljilany, Islam
    Hardikar, Sheetal
    Husain, Marium
    Ikeguchi, Alexandra P.
    Jin, Ning
    Ma, Qin
    McCarter, Martin D.
    Osman, Afaf E. G.
    Robinson, Lary A.
    Singer, Eric A.
    Tinoco, Gabriel
    Ulrich, Cornelia M.
    Zakharia, Yousef
    Spakowicz, Daniel
    Tarhini, Ahmad A.
    Tan, Aik Choon
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (08): : 1978 - 1990
  • [9] Prognostic Risk Stratification and End-of-Life Care Outcomes in Patients With Metastatic Melanoma Treated With Immune Checkpoint Inhibitors
    Grad, Robert N.
    Jung, Seungyeon
    Ye, Fei
    Sun, Lili
    Johnson, Douglas B.
    Agarwal, Rajiv
    ONCOLOGIST, 2023, 28 (10): : 911 - 916
  • [10] Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis
    Yamada, Kayoko
    Takeuchi, Masaki
    Fukumoto, Takeshi
    Suzuki, Minako
    Kato, Ai
    Mizuki, Yuki
    Yamada, Norihiro
    Kaneko, Takeshi
    Mizuki, Nobuhisa
    Horita, Nobuyuki
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345